Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and ADPKD

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with ADPKD in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research Excerpts

ExcerptRelevanceReference
"There are many parallels between ADPKD and clear-cell renal cell carcinoma (ccRCC); however, few studies have addressed the mechanisms linking them."1.62NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models. ( Chen, S; Fu, L; Huang, L; Mao, Z; Mei, C; Ruan, M; Xu, D; Yang, B; Zhang, Q; Zhou, S, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, S1
Huang, L1
Zhou, S1
Zhang, Q1
Ruan, M1
Fu, L1
Yang, B1
Xu, D1
Mei, C1
Mao, Z1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and ADPKD

ArticleYear
NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:20

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Computational Biology; Cyclooxygenase Inhi

2021